Google and Verily Life Sciences, a subsidiary within Alphabet, focused on developing health-tech, have revealed the fruits of a combined effort to harness AI to provide tools to healthcare professionals.
In this particular case, Google announced that AI technology it had developed was able to predict, with 70% accuracy, the risk of a cardiovascular event for patients over a five-year period, only 2% inferior to tests currently in use.
The AI works not by analysing blood samples but instead by examining images of the retinas of patients.
